<DOC>
	<DOCNO>NCT02035644</DOCNO>
	<brief_summary>The aim present study evaluate efficacy safety Jinlida granules patient inadequately control type-2 diabetes dyslipidemia life style intervention .</brief_summary>
	<brief_title>Study Efficacy aNd Safety Jinlida Granules Patients With Inadequately cOntrolled tYpe-2 Diabetes dysLIpidemia Under liFe Style Intervention ( ENJOY LIFE Study )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>1. age 2070 year ; 2. diagnose type 2 diabetes inadequately control life style intervention 3 month screen ; 3 . HbA1c ≥6.5 % ≤10.0 % , fast plasma glucose ≥7 ≤13.3mmol/L baseline ; 4. diagnose dislipidemia triglyceride &gt; 150mg/dL ( 1.70mmol/L ) , and/or total cholesterol &gt; 200mg/dL ( 5.16mmol/L ) , and/or LDLc &gt; 100mg/dL ( 2.58mmol/L ) 5. body mass index ( BMI ) : 20 &lt; BMI &lt; 40 kg/m2 ; 1. moderate severe liver dysfunction , abnormal renal function ; 2. severe dysfunction heart ; 3. history acute diabetic complication include diabetic ketoacidosis hyperosmolar hyperglycemic nonketotic coma within 3 month ; 4. psychiatric disease severe infection ; 5. pregnancy plan pregnancy ; 6. use drug ( include insulin ) treatment diabetes dyslipidemia within 3 month ; 7. use chronic ( &gt; 7 day ) systemic glucocorticoid therapy within 8 week receive growth hormone therapy within 6 month ; 8. diagnose type 1 diabetes , gestational diabetes , specific type diabetes ; 9. history malignant tumor within 5 year .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>